Literature DB >> 24863753

Current and newer agents for hypertensive emergencies.

Alan Padilla Ramos1, Joseph Varon.   

Abstract

Hypertension is an increasingly prevalent chronic illness. The condition may present as a hypertensive crisis, and this entity may be further categorized as either hypertensive emergency or urgency. As the presentation is quite variable and is dependent upon the specific end-organ injury, a thorough history and examination are necessary. Once the underlying pathology is known, a target blood pressure can be determined and a specific therapeutic agent selected. The choice of most appropriate agent must take into consideration coexisting morbidities, desired rate of blood pressure decline, monitoring capabilities of the environment, and experience of the clinician. In hypertensive emergencies, the therapeutic goal is to protect remaining end-organ function, reduce the risk of complications, and thereby improve patient outcomes. This article reviews commonly used antihypertensive medications as well as evidence-based recommendations for state-of-the-art treatment for hypertensive emergencies.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24863753     DOI: 10.1007/s11906-014-0450-z

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


  80 in total

1.  Advances in the acute therapy of hypertension.

Authors:  M G Ziegler
Journal:  Crit Care Med       Date:  1992-12       Impact factor: 7.598

Review 2.  Perioperative hypertensive crisis: newer concepts.

Authors:  Manuel L Fontes; Joseph Varon
Journal:  Int Anesthesiol Clin       Date:  2012

Review 3.  Acute thoracic aortic dissection: the basics.

Authors:  K Chen; J Varon; O C Wenker; D K Judge; R E Fromm; G L Sternbach
Journal:  J Emerg Med       Date:  1997 Nov-Dec       Impact factor: 1.484

4.  Nitroprusside-induced intracranial hypertension.

Authors:  W R Griswold; V Reznik; S A Mendoza
Journal:  JAMA       Date:  1981-12-11       Impact factor: 56.272

5.  The pathogenesis of acute pulmonary edema associated with hypertension.

Authors:  S K Gandhi; J C Powers; A M Nomeir; K Fowle; D W Kitzman; K M Rankin; W C Little
Journal:  N Engl J Med       Date:  2001-01-04       Impact factor: 91.245

Review 6.  Pharmacological effects of labetalol in man.

Authors:  D A Richards
Journal:  Br J Clin Pharmacol       Date:  1976-08       Impact factor: 4.335

7.  The diagnosis and treatment of hypertensive crises.

Authors:  Joseph Varon
Journal:  Postgrad Med       Date:  2009-01       Impact factor: 3.840

8.  Esmolol reduces perioperative ischemia in cardiac surgery: a meta-analysis of randomized controlled studies.

Authors:  Alberto Zangrillo; Stefano Turi; Giuseppe Crescenzi; Alessandro Oriani; Francesco Distaso; Fabrizio Monaco; Elena Bignami; Giovanni Landoni
Journal:  J Cardiothorac Vasc Anesth       Date:  2009-03-18       Impact factor: 2.628

9.  Pathophysiological events leading to the end-organ effects of acute hypertension.

Authors:  M J Ault; A G Ellrodt
Journal:  Am J Emerg Med       Date:  1985-12       Impact factor: 2.469

10.  CLUE: a randomized comparative effectiveness trial of IV nicardipine versus labetalol use in the emergency department.

Authors:  W Frank Peacock; Joseph Varon; Brigitte M Baumann; Pierre Borczuk; Chad M Cannon; Abhinav Chandra; David M Cline; Deborah Diercks; Brian Hiestand; A Hsu; Preeti Jois-Bilowich; Brian Kaminski; Philip Levy; Richard M Nowak; Jon W Schrock
Journal:  Crit Care       Date:  2011-06-27       Impact factor: 9.097

View more
  7 in total

Review 1.  Cardiovascular hypertensive emergencies.

Authors:  D P Papadopoulos; E A Sanidas; N A Viniou; V Gennimata; V Chantziara; I Barbetseas; T K Makris
Journal:  Curr Hypertens Rep       Date:  2015-02       Impact factor: 5.369

Review 2.  Clevidipine: a review of its use for managing blood pressure in perioperative and intensive care settings.

Authors:  Gillian M Keating
Journal:  Drugs       Date:  2014-10       Impact factor: 9.546

Review 3.  An Update on Inpatient Hypertension Management.

Authors:  R Neal Axon; Mason Turner; Ryan Buckley
Journal:  Curr Cardiol Rep       Date:  2015-11       Impact factor: 2.931

4.  Hypertensive Crisis, Burden, Management, and Outcome at a Tertiary Care Center in Karachi.

Authors:  Aysha Almas; Ayaz Ghouse; Ahmed Raza Iftikhar; Munawwar Khursheed
Journal:  Int J Chronic Dis       Date:  2014-08-18

Review 5.  Perioperative Use of Clevidipine: A Systematic Review and Meta-Analysis.

Authors:  Angel Espinosa; Javier Ripollés-Melchor; Rubén Casans-Francés; Alfredo Abad-Gurumeta; Sergio D Bergese; Alix Zuleta-Alarcon; Francisco López-Timoneda; José María Calvo-Vecino
Journal:  PLoS One       Date:  2016-03-28       Impact factor: 3.240

6.  Characteristics, treatment, and outcome of patients with hypertensive crisis admitted to University of Gondar Specialized Hospital, northwest Ethiopia: A cross-sectional study.

Authors:  Begashaw Melaku Gebresillassie; Yabsira Belayneh Debay
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-09-23       Impact factor: 3.738

Review 7.  Management of hypertensive crises in the elderly.

Authors:  Abbas Alshami; Carlos Romero; America Avila; Joseph Varon
Journal:  J Geriatr Cardiol       Date:  2018-07       Impact factor: 3.327

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.